Literature DB >> 14960756

Leukotriene-receptor inhibition for the treatment of systemic mastocytosis.

Jakub Tolar, Whitney D Tope, Joseph P Neglia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14960756     DOI： 10.1056/NEJM200402123500723

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

Review 1.  The Role of KIT Mutations in Anaphylaxis.

Authors:  Elise Coulson; Sherry Zhou; Cem Akin
Journal:  Curr Allergy Asthma Rep       Date:  2019-04-26       Impact factor: 4.806

2.  Mast cells in gastrointestinal disease.

Authors:  David B Ramsay; Sindu Stephen; Marie Borum; Lysandra Voltaggio; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-12

Review 3.  Mastocytosis: update on pharmacotherapy and future directions.

Authors:  Juan Carlos Cardet; Cem Akin; Min Jung Lee
Journal:  Expert Opin Pharmacother       Date:  2013-10       Impact factor: 3.889

4.  New developments in the field of mastocytosis and mast cell activation syndromes: a summary of the Annual Meeting of the European Competence Network on Mastocytosis (ECNM) 2019.

Authors:  Michel Arock; Karl Sotlar; Jason Gotlib; Wolfgang R Sperr; Karin Hartmann; Lawrence B Schwartz; Cem Akin; Hans-Peter Horny; Peter Valent
Journal:  Leuk Lymphoma       Date:  2019-12-26

5.  A Granular Approach to a Patient with Diarrhea and Flushing.

Authors:  Anas Gremida; Fazia Mir; Denis McCarthy
Journal:  Dig Dis Sci       Date:  2019-07       Impact factor: 3.487

6.  Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study.

Authors:  Dirk Schäfer; Peter Dreßen; Stefan Brettner; Norbert-Folke Rath; Gerhard J Molderings; Katrin Jensen; Christina Ziemann
Journal:  J Transl Med       Date:  2014-08-12       Impact factor: 5.531

Review 7.  Telangiectasia macularis eruptiva perstans: more than skin deep.

Authors:  Casey E Watkins; Winston B Bokor; Stuart Leicht; George Youngberg; Guha Krishnaswamy
Journal:  Dermatol Reports       Date:  2011-07-29

Review 8.  Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.

Authors:  David González-de-Olano; Almudena Matito; Alberto Orfao; Luis Escribano
Journal:  F1000Res       Date:  2016-11-14

Review 9.  Pharmacological treatment options for mast cell activation disease.

Authors:  Gerhard J Molderings; Britta Haenisch; Stefan Brettner; Jürgen Homann; Markus Menzen; Franz Ludwig Dumoulin; Jens Panse; Joseph Butterfield; Lawrence B Afrin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-30       Impact factor: 3.000

Review 10.  Mast Cell Clonal Disorders: Classification, Diagnosis and Management.

Authors:  Merel C Onnes; Luciana K Tanno; Joanne N G Oude Elberink
Journal:  Curr Treat Options Allergy       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.